Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Silva Carvalho, Ricardo ^a,b   Baltazar, Fátima ^a,b   Almeida Aguiar, Cristina ^c  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; IMMUNOMODULATING AGENT; PROPOLIS;

ALLOPATHY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CHEMICAL COMPOSITION; DRUG ACTIVITY; HONEYBEE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84935873710     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/206439     Document Type: Review

References (218)

1. M. Gordaliza, "Natural products as leads to anticancer drugs," Clinical and Translational Oncology, vol. 9, no. 12, pp. 767-776, 2007.
2. D. J. Newman and G. M. Cragg, "Natural products as sources of new drugs over the last 25 years," Journal of Natural Products, vol. 70, no. 3, pp. 461-477, 2007.
3. M. A. E. Watanabe, M. K. Amarante, B. J. Conti, and J. M. Sforcin, "Cytotoxic constituents of propolis inducing anticancer effects: a review," Journal of Pharmacy and Pharmacology, vol. 63, no. 11, pp. 1378-1386, 2011.
4. K.-H. Lee, "Current developments in the discovery and design of new drug candidates from plant natural product leads," Journal of Natural Products, vol. 67, no. 2, pp. 273-283, 2004.
5. S. Umthong, P. Phuwapraisirisan, S. Puthong, and C. Chanchao, "In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines," BMC Complementary and Alternative Medicine, vol. 11, article 37, 2011.
6. J. M. Sforcin and V. Bankova, "Propolis: is there a potential for the development of new drugs?" Journal of Ethnopharmacology, vol. 133, no. 2, pp. 253-260, 2011.
7. M. Marcucci, "Propolis: chemical composition, biological properties and therapeutic activity," Apidologie, vol. 26, no. 2, pp. 83-99, 1995.
8. Y. Barlak, O. Deger, M. Colak, S. C. Karatayli, A. M. Bozdayi, and F. Yucesan, "Effect of Turkish propolis extracts on proteome of prostate cancer cell line," Proteome Science, vol. 9, article 74, 2011.
9. V. Bankova, "Chemical diversity of propolis and the problem of standardization," Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 114-117, 2005.
10. V. S. Bankova, S. L. de Castro, and M. C. Marcucci, "Propolis: recent advances in chemistry and plant origin," Apidologie, vol. 31, no. 1, pp. 3-15, 2000.
11. S. M. Cardoso, M. Ribeiro, I. L. Ferreira, and A. Cristina Rego, "Northeast Portuguese propolis protects against staurosporine and hydrogen peroxide-induced neurotoxicity in primary cortical neurons," Food and Chemical Toxicology, vol. 49, no. 11, pp. 2862-2868, 2011.
12. H. Fokt, A. Pereira, A. M. Ferreira, A. Cunha, and C. Aguiar, "How do bees prevent hive infections? The antimicrobial properties of propolis," in Current Research, Technology and Education Topics in AppliedMicrobiology andMicrobial Biotechnology, A. Mendez-Vilas, Ed., vol. 1 of Microbiology Book Series-Number 2, pp. 481-493, 2010.
13. G. M. Sulaiman, A. H. Adhiah, K. W. Al-Sammarrae et al., "Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo," Food and Chemical Toxicology, vol. 50, no. 5, pp. 1632-1641, 2012.
14. N. Orsolic, S. Terzic, Z. Mihaljevic, L. Sver, and I. Basic, "Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth," Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp. 1928-1933, 2005.
15. S. Castaldo and F. Capasso, "Propolis, an old remedy used in modern medicine," Fitoterapia, vol. 73, supplement 1, pp. S1-S6, 2002.
16. G. A. Burdock, "Review of the biological properties and toxicity of bee propolis (propolis)," Food and Chemical Toxicology, vol. 36, no. 4, pp. 347-363, 1998.
17. M. L. Khalil, "Biological activity of bee propolis in health and disease," Asian Pacific Journal of Cancer Prevention, vol. 7, no. 1, pp. 22-31, 2006.
18. J. B. Daleprane, V. da Silva Freitas, A. Pacheco et al., "Antiatherogenic and anti-angiogenic activities of polyphenols from propolis," Journal of Nutritional Biochemistry, vol. 23, no. 6, pp. 557-566, 2012.
19. A. H. Banskota, Y. Tezuka, and S. Kadota, "Recent progress in pharmacological research of propolis," Phytotherapy Research, vol. 15, no. 7, pp. 561-571, 2001.
20. S. I. Falcao, M. Vilas-Boas, L. M. Estevinho, C. Barros, M. R. M. Domingues, and S. M. Cardoso, "Phenolic characterization of Northeast Portuguese propolis: usual and unusual compounds," Analytical and Bioanalytical Chemistry, vol. 396, no. 2, pp. 887-897, 2010.
21. S. I. Falcao, N. Vale, P. Gomes et al., "Phenolic profiling of Portuguese propolis by LC-MS spectrometry: uncommon propolis rich in flavonoid glycosides," Phytochemical Analysis, vol. 24, no. 4, pp. 309-318, 2013.
22. L.-P. Sun, A.-L. Chen, H.-C. Hung et al., "Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis," Journal of Agricultural and Food Chemistry, vol. 60, no. 47, pp. 11748-11758, 2012.
23. R. Silva-Carvalho, V. Miranda-Goncalves, A. M. Ferreira et al., "Antitumoural and antiangiogenic activity of Portuguese propolis in in vitro and in vivo models," Journal of Functional Foods, vol. 11, pp. 160-171, 2014.
24. M. P. Popova, K. Graikou, I. Chinou, and V. S. Bankova, "GCMS profiling of diterpene compounds in mediterranean propolis fromGreece," Journal ofAgricultural andFoodChemistry, vol. 58, no. 5, pp. 3167-3176, 2010.
25. O. G. Celemli, F. Hatjina, L. Charistos, A. Schiesser, and A. Ozkirim, "More insight into the chemical composition of Greek propolis; differences and similarities with Turkish propolis," Zeitschrift fur Naturforschung C, vol. 68, no. 11-12, pp. 429-438, 2013.
26. V. Bankova, M. Popova, S. Bogdanov, and A.-G. Sabatini, "Chemical composition of European propolis: expected and unexpected results," Zeitschrift fur Naturforschung Section C, vol. 57, no. 5-6, pp. 530-533, 2002.
27. M. Popova, B. Trusheva, D. Antonova et al., "The specific chemical profile of Mediterranean propolis from Malta," Food Chemistry, vol. 126, no. 3, pp. 1431-1435, 2011.
28. M. Velikova, V. Bankova, K. Sorkun, S. Houcine, I. Tsvetkova, and A. Kujumgiev, "Propolis from the Mediterranean region: chemical composition and antimicrobial activity," Zeitschrift fur Naturforschung C, vol. 55, no. 9-10, pp. 790-793, 2000.
29. S. Silici, M. Unlu, and G. Vardar-Unlu, "Antibacterial activity and phytochemical evidence for the plant origin of Turkish propolis from different regions," World Journal of Microbiology and Biotechnology, vol. 23, no. 12, pp. 1797-1803, 2007.
30. N. Duran, M. Muz, G. Culha, G. Duran, and B. Ozer, "GC-MS analysis and antileishmanial activities of two Turkish propolis types," Parasitology Research, vol. 108, no. 1, pp. 95-105, 2011.
31. A. L. Piccinelli, T. Mencherini, R. Celano et al., "Chemical composition and antioxidant activity of Algerian propolis," Journal of Agricultural and Food Chemistry, vol. 61, no. 21, pp. 5080-5088, 2013.
32. Y. K. Park, S. M. Alencar, and C. L. Aguiar, "Botanical origin and chemical composition of Brazilian propolis," Journal of Agricultural and Food Chemistry, vol. 50, no. 9, pp. 2502-2506, 2002.
33. C. O. da Silva Frozza, C. S. C. Garcia, G. Gambato et al., "Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis,"FoodandChemical Toxicology, vol. 52, pp. 137-142, 2013.
34. A. Daugsch, C. S. Moraes, P. Fort, and Y. K. Park, "Brazilian red propolis-chemical composition and botanical origin," Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 435-441, 2008.
35. B. B. Silva, P. L. Rosalen, J. A. Cury et al., "Chemical composition and botanical origin of red propolis, a new type of Brazilian propolis," Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 3, pp. 313-316, 2008.
36. O. Cuesta-Rubio, B. A. Frontana-Uribe, T. Ramirez-Apan, and J. Cardenas, "Polyisoprenylated benzophenones in Cuban propolis; biological activity of nemorosone," Zeitschrift fur Naturforschung C, vol. 57, no. 3-4, pp. 372-378, 2002.
37. B. Trusheva, M. Popova, H. Naydenski, I. Tsvetkova, J. G. Rodriguez, and V. Bankova, "New polyisoprenylated benzophenones from Venezuelan propolis," Fitoterapia, vol. 75, no. 7-8, pp. 683-689, 2004.
38. F. A. Tomas-Barberan, C. Garcia-Viguera, P. Vit-Olivier, F. Ferreres, and F. Tomas-Lorente, "Phytochemical evidence for the botanical origin of tropical propolis from Venezuela," Phytochemistry, vol. 34, no. 1, pp. 191-196, 1993.
39. A. Abu-Mellal, N. Koolaji, R. K. Duke, V. H. Tran, and C. C. Duke, "Prenylated cinnamate and stilbenes from Kangaroo Island propolis and their antioxidant activity," Phytochemistry, vol. 77, pp. 251-259, 2012.
40. V. H. Tran, R. K. Duke, A. Abu-Mellal, and C. C. Duke, "Propolis with high flavonoid content collected by honey bees from Acacia paradoxa," Phytochemistry, vol. 81, pp. 126-132, 2012.
41. E. L. Ghisalberti, P. R. Jefferies, R. Lanteri, and J. Matisons, "Constituents of propolis," Experientia, vol. 34, no. 2, pp. 157-158, 1978.
42. C. F. Massaro, M. Katouli, T. Grkovic et al., "Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae)," Fitoterapia, vol. 95, pp. 247-257, 2014.
43. S. Kumazawa, H. Goto, T. Hamasaka, S. Fukumoto, T. Fujimoto, and T. Nakayama, "A new prenylated flavonoid from propolis collected in Okinawa, Japan," Bioscience, Biotechnology and Biochemistry, vol. 68, no. 1, pp. 260-262, 2004.
44. S. Inui, T. Hosoya, and S. Kumazawa, "Hawaiian propolis: comparative analysis and botanical origin," Natural Product Communications, vol. 9, no. 2, pp. 165-166, 2014.
45. C.-N. Chen, C.-J. Hsiao, S.-S. Lee et al., "Chemical modification and anticancer effect of prenylated flavanones from Taiwanese propolis," Natural Product Research, vol. 26, no. 2, pp. 116-124, 2012.
46. B. Trusheva, M. Popova, E. B. Koendhori, I. Tsvetkova, C. Naydenski, and V. Bankova, "Indonesian propolis: chemical composition, biological activity and botanical origin," Natural Product Research, vol. 25, no. 6, pp. 606-613, 2011.
47. F. Li, S. Awale, H. Zhang, Y. Tezuka, H. Esumi, and S. Kadota, "Chemical constituents of propolis from Myanmar and their preferential cytotoxicity against a human pancreatic cancer cell line," Journal of Natural Products, vol. 72, no. 7, pp. 1283-1287, 2009.
48. S. Athikomkulchai, S. Awale, N. Ruangrungsi, S. Ruchirawat, and S. Kadota, "Chemical constituents ofThai propolis," Fitoterapia, vol. 88, pp. 96-100, 2013.
49. V. S. Bankova, R. S. Christov, and A. D. Tejera, "Lignans and other constituents of propolis from the canary islands," Phytochemistry, vol. 49, no. 5, pp. 1411-1415, 1998.
50. A. Petrova, M. Popova, C. Kuzmanova et al., "New biologically active compounds from Kenyan propolis," Fitoterapia, vol. 81, no. 6, pp. 509-514, 2010.
51. M. Popova, R. Dimitrova, H. T. Al-Lawati, I. Tsvetkova, H. Najdenski, and V. Bankova, "Omani propolis: chemical profiling, antibacterial activity and newpropolis plant sources," Chemistry Central Journal, vol. 7, no. 1, article 158, 2013.
52. A. I. Rushdi, N. Adgaba, N. I. Bayaqoob et al., "Characteristics and chemical compositions of propolis from Ethiopia," SpringerPlus, vol. 3, no. 1, p. 253, 2014.
53. D. Papachroni, K. Graikou, I. Kosalec, H. Damianakos, V. Ingram, and I. Chinou, "Phytochemical analysis and biological evaluation of selectedAfrican propolis samples fromCameroon and Congo," Natural Product Communications, vol. 10, no. 1, pp. 67-70, 2015.
54. T. Zhang, R. Omar, W. Siheri et al., "Chromatographic analysis with different detectors in the chemical characterisation and dereplication of African propolis," Talanta, vol. 120, pp. 181-190, 2014.
55. A. Kurek-Gorecka, A. Rzepecka-Stojko, M. Gorecki, J. Stojko, M. Sosada, and G. Swierczek-Zieba, "Structure and antioxidant activity of polyphenols derived from propolis," Molecules, vol. 19, no. 1, pp. 78-101, 2014.
56. F. Scazzocchio, F. D. DAuria, D. Alessandrini, and F. Pantanella, "Multifactorial aspects of antimicrobial activity of propolis," Microbiological Research, vol. 161, no. 4, pp. 327-333, 2006.
57. R. M. Ordonez, I. C. Zampini, M. I. N. Moreno, and M. I. Isla, "Potential application of Northern Argentine propolis to control some phytopathogenic bacteria," Microbiological Research, vol. 166, no. 7, pp. 578-584, 2011.
58. J. C. Silva, S. Rodrigues, X. Feas, and L. M. Estevinho, "Antimicrobial activity, phenolic profile and role in the inflammation of propolis," Food and Chemical Toxicology, vol. 50, no. 5, pp. 1790-1795, 2012.
59. A. Kujumgiev, I. Tsvetkova, Y. Serkedjieva, V. Bankova, R. Christov, and S. Popov, "Antibacterial, antifungal and antiviral activity of propolis of different geographic origin," Journal of Ethnopharmacology, vol. 64, no. 3, pp. 235-240, 1999.
60. M. Amoros, C. M. O. Simoes, L. Girre, F. Sauvager, and M. Cormier, "Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparisonwith the antiviral activity of propolis," Journal of Natural Products, vol. 55, no. 12, pp. 1732-1740, 1992.
61. F. Hu, H. R. Hepburn, Y. Li, M. Chen, S. E. Radloff, and S. Daya, "Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models," Journal of Ethnopharmacology, vol. 100, no. 3, pp. 276-283, 2005.
62. L. Moreira, L. G. Dias, J. A. Pereira, and L. Estevinho, "Antioxidant properties, total phenols and pollen analysis of propolis samples from Portugal," Food and Chemical Toxicology, vol. 46, no. 11, pp. 3482-3485, 2008.
63. M. G. Miguel, S. Nunes, S. A. Dandlen, A. M. Cavaco, and M. D. Antunes, "Phenols and antioxidant activity of hydro-alcoholic extracts of propolis from Algarve, South of Portugal," Food and Chemical Toxicology, vol. 48, no. 12, pp. 3418-3423, 2010.
64. M. J. Valente, A. F. Baltazar, R. Henrique, L. Estevinho, and M. Carvalho, "Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro," Food and Chemical Toxicology, vol. 49, no. 1, pp. 86-92, 2011.
65. N. Orsolic and I. Basic, "Immunomodulation by water-soluble derivative of propolis: a factor of antitumor reactivity," Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 265-273, 2003.
66. G. C.-F. Chan, K.-W. Cheung, and D. M.-Y. Sze, "The immunomodulatory and anticancer properties of propolis," Clinical Reviews in Allergy and Immunology, vol. 44, no. 3, pp. 262-273, 2013.
67. R. C. Calhelha, S. Falcao, M. J. Queiroz, M. Vilas-Boas, and I. C. Ferreira, "Cytotoxicity of portuguese propolis: the proximity of the in vitro doses for tumor and normal cell lines," BioMed Research International, vol. 2014, 7 pages, 2014.
68. V. Sosa, T. Moline, R. Somoza, R. Paciucci, H. Kondoh, and M. E. LLeonart, "Oxidative stress and cancer: an overview," Ageing Research Reviews, vol. 12, no. 1, pp. 376-390, 2013.
69. T. B. Salmon, B. A. Evert, B. Song, and P. W. Doetsch, "Biological consequences of oxidative stress-induced DNA damage in Saccharomyces cerevisiae," Nucleic Acids Research, vol. 32, no. 12, pp. 3712-3723, 2004.
70. M. Viuda-Martos, Y. Ruiz-Navajas, J. Fernandez-Lopez, and J. A. Perez-Alvarez, "Functional properties of honey, propolis, and royal jelly," Journal of Food Science, vol. 73, no. 9, pp. R117-R124, 2008.
71. Z. Wu, Y. Zhao, and B. Zhao, "Superoxide anion, uncoupling proteins and Alzheimers disease," Journal of Clinical Biochemistry and Nutrition, vol. 46, no. 3, pp. 187-194, 2010.
72. F. J. Pashkow, "Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?" International Journal of Inflammation, vol. 2011, Article ID 514623, 9 pages, 2011.
73. R. Schnabel and S. Blankenberg, "Oxidative stress in cardiovascular disease: successful translation from bench to bedside?" Circulation, vol. 116, no. 12, pp. 1338-1340, 2007.
74. W. Ladiges, J. Wanagat, B. Preston, L. Loeb, and P. Rabinovitch, "A Mitochondrial view of aging, reactive oxygen species and metastatic cancer," Aging Cell, vol. 9, no. 4, pp. 462-465, 2010.
75. M. A. Nader, D. S. El-Agamy, and G. M. Suddek, "Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits," Archives of Pharmacal Research, vol. 33, no. 4, pp. 637-643, 2010.
76. A. Scalbert, I. T. Johnson, and M. Saltmarsh, "Polyphenols: antioxidants and beyond," The American Journal of Clinical Nutrition, vol. 81, no. 1, supplement, pp. 215S-217S, 2005.
77. N. Almaraz-Abarca, M. da Graca Campos, J. A. Avila-Reyes, N. Naranjo-Jimenez, J. Herrera Corral, and L. S. Gonzalez-Valdez, "Antioxidant activity of polyphenolic extract of monofloral honeybee-collected pollen from mesquite (Prosopis juliflora, Leguminosae)," Journal of Food Composition and Analysis, vol. 20, no. 2, pp. 119-124, 2007.
78. S. Fabris, M. Bertelle, O. Astafyeva et al., "Antioxidant properties and chemical composition relationship of europeans and Brazilians propolis," Pharmacology and Pharmacy, vol. 4, no. 1, pp. 46-51, 2013.
79. C. M. Mihai, L. A. Marghitas, D. S. Daniel, S. Dezmirean, and L. Barnutiu, "Correlation between polyphenolic profile and antioxidant activity of propolis from Transylvania," Animal Science and Biotechnologies, vol. 44, no. 2, pp. 100-103, 2011.
80. G. G. Duthie, P. T. Gardner, and J. A. M. Kyle, "Plant polyphenols: are they the newmagic bullet?" Proceedings of theNutrition Society, vol. 62, no. 3, pp. 599-603, 2003.
81. H. Yang, Y. Dong, H. Du, H. Shi, Y. Peng, and X. Li, "Antioxidant compounds from propolis collected in Anhui, China," Molecules, vol. 16, no. 4, pp. 3444-3455, 2011.
82. V. Silva, G. Genta, M. N. Moller et al., "Antioxidant activity of Uruguayan propolis. In vitro and cellular assays," Journal of Agricultural and Food Chemistry, vol. 59, no. 12, pp. 6430-6437, 2011.
83. P. Bolfa, R. Vidrighinescu, A. Petruta et al., "Photoprotective effects of Romanian propolis on skin of mice exposed to UVB irradiation,"FoodandChemical Toxicology, vol. 62, pp. 329-342, 2013.
84. Z. Talas, I. Ozdemir, O. Ciftci, M. Gulhan, and A. Savci, "Antioxidant effect of ethanolic extract of propolis in liver of L-name treated rats," Advances in Clinical and Experimental Medicine, vol. 24, no. 2, pp. 227-232, 2015.
85. A. Russo, R. Longo, and A. Vanella, "Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin," Fitoterapia, vol. 73, supplement 1, pp. S21-S29, 2002.
86. M. Hosnuter, A. Gurel, O. Babuccu, F. Armutcu, E. Kargi, and A. Isikdemir, "The effect of CAPE on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury," Burns, vol. 30, no. 2, pp. 121-125, 2004.
87. Y.-J. Chen, A.-C. Huang, H.-H. Chang et al., "Caffeic acid phenethyl ester, an antioxidant from propolis, protects peripheral blood mononuclear cells of competitive cyclists against hyperthermal stress," Journal of Food Science, vol. 74, no. 6, pp. H162-H167, 2009.
88. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, "Oxidative stress, inflammation, and cancer: how are they linked?" Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603-1616, 2010.
89. G. Costa, V. Francisco, M. C. Lopes, M. T. Cruz, and M. T. Batista, "Intracellular signaling pathways modulated by phenolic compounds: application for new anti-inflammatory drugs discovery," Current Medicinal Chemistry, vol. 19, no. 18, pp. 2876-2900, 2012.
90. O. K. Mirzoeva and P. C. Calder, "The effect of propolis and its components on eicosanoid production during the inflammatory response," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 55, no. 6, pp. 441-449, 1996.
91. A. Rossi, A. Ligresti, R. Longo, A. Russo, F. Borrelli, and L. Sautebin, "The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages," Phytomedicine, vol. 9, no. 6, pp. 530-535, 2002.
92. S. Chirumbolo, "The role of quercetin, flavonols and flavones in modulating inflammatory cell function," Inflammation and Allergy-Drug Targets, vol. 9, no. 4, pp. 263-285, 2010.
93. E.-H. Park and J.-H. Kahng, "Suppressive effects of propolis in rat adjuvant arthritis," Archives of Pharmacal Research, vol. 22, no. 6, pp. 554-558, 1999.
94. N. Marquez, R. Sancho, A. Macho, M. A. Calzado, B. L. Fiebich, and E. Munoz, "Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-κB transcription factors," Journal of Pharmacology and Experimental Therapeutics, vol. 308, no. 3, pp. 993-1001, 2004.
95. Y. Naito, M. Yasumuro, K. Kondou, and N. Ohara, "Antiinflammatory effect of topically applied propolis extract in carrageenan-induced rat hind paw edema," Phytotherapy Research, vol. 21, no. 5, pp. 452-456, 2007.
96. M. Funakoshi-Tago, K. Okamoto, R. Izumi et al., "Antiinflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway," International Immunopharmacology, vol. 25, no. 1, pp. 189-198, 2015.
97. R. M. N. Bezerra, L. F. Veiga, A. C. Caetano et al., "Caffeic acid phenethyl ester reduces the activation of the nuclear factor kappab pathway by high-fat diet-induced obesity in mice," Metabolism: Clinical and Experimental, vol. 61, no. 11, pp. 1606-1614, 2012.
98. S. Juman, N. Yasui, K. Ikeda et al., "Caffeic acid phenethyl ester suppresses the production of pro-inflammatory cytokines in hypertrophic adipocytes through lipopolysaccharidestimulated macrophages," Biological and Pharmaceutical Bulletin, vol. 35, no. 11, pp. 1941-1946, 2012.
99. J. L. Machado, A. K. Assuncao, M. C. da Silva et al., "Brazilian green propolis: anti-inflammatory property by an immunomodulatory activity," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 157652, 10 pages, 2012.
100. F. Teles, T. M. da Silva, F. P. da Cruz Junior et al., "Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model," PLoS ONE, vol. 10, no. 1, Article ID e0116535, 2015.
101. M. C. Bufalo, I. Ferreira, G. Costa et al., "Propolis and its constituent caffeic acid suppress LPS-stimulated proinflammatory response by blocking NF-κB andMAPK activation in macrophages," Journal of Ethnopharmacology, vol. 149, no. 1, pp. 84-92, 2013.
102. G. Valenzuela-Barra, C. Castro, C. Figueroa et al., "Antiinflammatory activity and phenolic profile of propolis from two locations in RegionMetropolitana de Santiago, Chile," Journal of Ethnopharmacology, vol. 168, pp. 37-44, 2015.
103. L. H. Boudreau, J. Maillet, L. M. LeBlanc et al., "Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes," PLoS ONE, vol. 7, no. 2, Article ID e31833, 2012.
104. N. Orsolic, J. Skuric, D. Dikic, and G. Stanic, "Inhibitory effect of a propolis on Di-n-Propyl Disulfide or n-Hexyl salycilate-induced skin irritation, oxidative stress and inflammatory responses in mice," Fitoterapia, vol. 93, pp. 18-30, 2014.
105. C. L. Orsatti, F. Missima, A. C. Pagliarone et al., "Propolis immunomodulatory action in vivo on toll-like receptors 2 and expression and on pro-inflammatory cytokines production in mice," Phytotherapy Research, vol. 24, no. 8, pp. 1141-1146, 2010.
106. N. Ivanovska, H. Neychev, Z. Stefanova, V. Bankova, and S. Popov, "Influence of cinnamic acid on lymphocyte proliferation, cytokine release and Klebsiella infection in mice," Apidologie, vol. 26, no. 2, pp. 73-81, 1995.
107. R. O. Orsi, S. R. Funari, A. M. V. C. Soares, and et al, "Immunomodulatory action of propolis onmacrophage activation," Journal of Venomous Animals and Toxins, vol. 6, no. 2, pp. 205-219, 2000.
108. A. Sa-Nunes, L. H. Faccioli, and J. M. Sforcin, "Propolis: Lymphocyte proliferation and IFN-β production," Journal of Ethnopharmacology, vol. 87, no. 1, pp. 93-97, 2003.
109. F. Missima and J. M. Sforcin, "Green Brazilian propolis action on macrophages and lymphoid organs of chronically stressed mice," Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 71-75, 2008.
110. Syamsudin, R. M. Dewi, and Kusmardi, "Immunomodulatory and in vivo antiplasmodial activities of propolis extracts," American Journal of Pharmacology and Toxicology, vol. 4, no. 3, pp. 75-79, 2009.
111. C. L. Orsatti and J. M. Sforcin, "Propolis immunomodulatory activity on TLR-2 and TLR-4 expression by chronically stressed mice," Natural Product Research, vol. 26, no. 5, pp. 446-453, 2012.
112. L.-C. Wang, Y.-L. Lin, Y.-C. Liang et al., "The effect of caffeic acid phenethyl ester on the functions of human monocytederived dendritic cells," BMC Immunology, vol. 10, article 39, 2009.
113. M. C. Bufalo, A. P. Bordon-Graciani, B. J. Conti, M. de Assis Golim, and J. M. Sforcin, "The immunomodulatory effect of propolis on receptors expression, cytokine production and fungicidal activity of human monocytes," Journal of Pharmacy and Pharmacology, vol. 66, no. 10, pp. 1497-1504, 2014.
114. M. C. Bufalo and J. M. Sforcin, "Themodulatory effects of caffeic acid on human monocytes and its involvement in propolis action," Journal of Pharmacy and Pharmacology, vol. 67, no. 5, pp. 740-745, 2015.
115. F. Missima, A. C. Pagliarone, C. L. Orsatti, and J. M. Sforcin, "The effect of propolis on pro-inflammatory cytokines produced by melanoma-bearing mice submitted to chronic stress," Journal of ApiProduct and ApiMedical Science, vol. 1, no. 1, pp. 11-15, 2009.
116. T. F. Bachiega, C. L. Orsatti, A. C. Pagliarone, and J. M. Sforcin, "The effects of propolis and its isolated compounds on cytokine production by murine macrophages," Phytotherapy Research, vol. 26, no. 9, pp. 1308-1313, 2012.
117. S. S. da Silva, S. Thome Gda, A. H. Cataneo et al., "Brazilian propolis antileishmanial and immunomodulatory effects," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 673058, 7 pages, 2013.
118. Y. Okamoto, T. Hara, T. Ebato, T. Fukui, and T. Masuzawa, "Brazilian propolis ameliorates trinitrobenzene sulfonic acidinduced colitis in mice by inhibitingTh1 differentiation," International Immunopharmacology, vol. 16, no. 2, pp. 178-183, 2013.
119. G. Gekker, S. Hu, M. Spivak, J. R. Lokensgard, and P. K. Peterson, "Anti-HIV-1 activity of propolis in CD4+ lymphocyte andmicroglial cell cultures," Journal of Ethnopharmacology, vol. 102, no. 2, pp. 158-163, 2005.
120. M. Amoros, F. Sauvager, L. Girre, and M. Cormier, "In vitro antiviral activity of propolis," Apidologie, vol. 23, no. 3, pp. 231-240, 1992.
121. J. Serkedjieva, N. Manolova, and V. Bankova, "Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids)," Journal of Natural Products, vol. 55, no. 3, pp. 294-297, 1992.
122. T. Shimizu, A. Hino, A. Tsutsumi, Y. K. Park, W. Watanabe, and M. Kurokawa, "Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice," Antiviral Chemistry and Chemotherapy, vol. 19, no. 1, pp. 7-13, 2008.
123. P. Schnitzler, A. Neuner, S. Nolkemper et al., "Antiviral activity and mode of action of propolis extracts and selected compounds," Phytotherapy Research, vol. 24, supplement 1, pp. S20-S28, 2010.
124. G. Sartori, A. P. Pesarico, S. Pinton et al., "Protective effect of brown Brazilian propolis against acute vaginal lesions caused by herpes simplex virus type 2 in mice: involvement of antioxidant and anti-inflammatory mechanisms," Cell Biochemistry and Function, vol. 30, no. 1, pp. 1-10, 2012.
125. G. R. Coelho, R. Z. Mendonca, K. D. Vilar et al., "Antiviral action of hydromethanolic extract of geopropolis from Scaptotrigona postica against antiherpes simplex virus (HSV-1)," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 296086, 10 pages, 2015.
126. S. Tait, A. L. Salvati, N. Desideri, and L. Fiore, "Antiviral activity of substituted homoisoflavonoids on enteroviruses," Antiviral Research, vol. 72, no. 3, pp. 252-255, 2006.
127. J. Shvarzbeyn and M. Huleihel, "Effect of propolis and caffeic acid phenethyl ester (CAPE) on NFκB activation by HTLV-1 Tax," Antiviral Research, vol. 90, no. 3, pp. 108-115, 2011.
128. X. Ma, Z. Guo, Z. Shen, Y. Liu, J. Wang, and Y. Fan, "The anti-porcine parvovirus activity of nanometer propolis flavone and propolis flavone in vitro and in vivo," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 472876, 10 pages, 2015.
129. J. Ito, F.-R. Chang, H.-K. Wang et al., "Anti-AIDS agents. 48. Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis," Journal of Natural Products, vol. 64, no. 10, pp. 1278-1281, 2001.
130. O. K. Mirzoeva, R. N. Grishanin, and P. C. Calder, "Antimicrobial action of propolis and some of its components: the effects on growth, membrane potential andmotility of bacteria," Microbiological Research, vol. 152, no. 3, pp. 239-246, 1997.
131. K. Cui, W. Lu, L. Zhu, X. Shen, and J. Huang, "Caffeic acid phenethyl ester (CAPE), an active component of propolis, inhibits Helicobacter pylori peptide deformylase activity," Biochemical and Biophysical Research Communications, vol. 435, no. 2, pp. 289-294, 2013.
132. R. D. Wojtyczka, A. Dziedzic, D. Idzik et al., "Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs," Molecules, vol. 18, no. 8, pp. 9623-9640, 2013.
133. S. Boisard, A. Le Ray, A. Landreau et al., "Antifungal and antibacterial metabolites from a French poplar type propolis," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID319240, 10 pages, 2015.
134. H. Katircioglu and N. Mercan, "Antimicrobial activity and chemical compositions of Turkish propolis from different regions," African Journal of Biotechnology, vol. 5, no. 11, pp. 1151-1153, 2006.
135. R. O. Orsi, A. Fernandes Jr., V. Bankova, and J. M. Sforcin, "Antibacterial effects of Brazilian and Bulgarian propolis and synergistic effects with antibiotics acting on the bacterial DNA and folic acid," Natural Product Research, vol. 26, no. 4, pp. 344-349, 2012.
136. L. Grenho, J. Barros, C. Ferreira et al., "In vitro antimicrobial activity and biocompatibility of propolis containing nanohydroxyapatite," Biomedical Materials, vol. 10, no. 2, Article ID 025004, 2015.
137. V. Seidel, E. Peyfoon, D. G. Watson, and J. Fearnley, "Comparative study of the antibacterial activity of propolis from different geographical and climatic zones," Phytotherapy Research, vol. 22, no. 9, pp. 1256-1263, 2008.
138. L. Monzote, O. Cuesta-Rubio, M. C. Fernandez et al., "In vitro antimicrobial assessment ofCuban propolis extracts,"Memorias do Instituto Oswaldo Cruz, vol. 107, no. 8, pp. 978-984, 2012.
139. L. G. Dias, A. P. Pereira, and L. M. Estevinho, "Comparative study of different Portuguese samples of propolis: pollinic, sensorial, physicochemical, microbiological characterization and antibacterial activity," Food and Chemical Toxicology, vol. 50, no. 12, pp. 4246-4253, 2012.
140. S. I. Falcao, N. Vale, P. Cos et al., "In vitro evaluation of portuguese propolis and floral sources for antiprotozoal, antibacterial and antifungal activity," Phytotherapy Research, vol. 28, no. 3, pp. 437-443, 2014.
141. C. Ota, C. Unterkircher, V. Fantinato, and M. T. Shimizu, "Antifungal activity of propolis on different species of Candida," Mycoses, vol. 44, no. 9-10, pp. 375-378, 2001.
142. J. M. Murad, S. A. Calvi, A. M. V. C. Soares, V. Bankova, and J. M. Sforcin, "Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages against Paracoccidioides brasiliensis," Journal of Ethnopharmacology, vol. 79, no. 3, pp. 331-334, 2002.
143. A. B. S. Siqueira, B. S. Gomes, I. Cambuim et al., "Trichophyton species susceptibility to green and red propolis from Brazil," Letters in Applied Microbiology, vol. 48, no. 1, pp. 90-96, 2009.
144. K. F. D. Dota, M. E. L. Consolaro, T. I. E. Svidzinski, and M. L. Bruschi, "Antifungal activity of brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 201953, 8 pages, 2011.
145. J. S. Bonvehi and A. L. Gutierrez, "The antimicrobial effects of propolis collected in different regions in the Basque Country (Northern Spain)," World Journal of Microbiology and Biotechnology, vol. 28, no. 4, pp. 1351-1358, 2012.
146. E. N. Quiroga, D. A. Sampietro, J. R. Soberon, M. A. Sgariglia, and M. A. Vattuone, "Propolis from the northwest of Argentina as a source of antifungal principles," Journal of AppliedMicrobiology, vol. 101, no. 1, pp. 103-110, 2006.
147. P. Szweda, K. Gucwa, E. Kurzyk et al., "Essential oils, silver nanoparticles and propolis as alternative agents against fluconazole resistant Candida albicans, Candida glabrata and Candida krusei clinical isolates," Indian Journal of Microbiology, vol. 55, no. 2, pp. 175-183, 2015.
148. B. Pippi, A. Lana, R. Moraes et al., "In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp," Journal of Applied Microbiology, vol. 118, no. 4, pp. 839-850, 2015.
149. I. R. G. Capoci, P. de Souza Bonfim-Mendonca, G. S. Arita et al., "Propolis is an efficient fungicide and inhibitor of biofilm production by vaginal Candida albicans," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 287693, 9 pages, 2015.
150. A. A. Berretta, P. A. de Castro, A. H. Cavalheiro et al., "Evaluation of mucoadhesive gels with propolis (EPP-AF) in preclinical treatment of candidiasis vulvovaginal infection," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID641480, 18 pages, 2013.
151. P. A. DeCastro, V. L. P. Bom, N. A. Brown et al., "Identification of the cell targets important for propolis-induced cell death in Candida albicans," Fungal Genetics and Biology, vol. 60, pp. 74-86, 2013.
152. D. Sawicka, H. Car, M. H. Borawska, and J. Niklinski, "Theanticancer activity of propolis," Folia Histochemica et Cytobiologica, vol. 50, no. 1, pp. 25-37, 2012.
153. J. R. Araujo, P. Goncalves, and F. Martel, "Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines," Nutrition Research, vol. 31, no. 2, pp. 77-87, 2011.
154. R. Kubina, A. Kabaa-Dzik, A. Dziedzic et al., "The ethanol extract of polish propolis exhibits anti-proliferative and/or proapoptotic effect on HCT 116 colon cancer and me45 malignant melanoma cells in vitro conditions," Advances in Clinical and Experimental Medicine, vol. 24, no. 2, pp. 203-212, 2015.
155. M. Ishihara, K. Naoi, M. Hashita, Y. Itoh, and M. Suzui, "Growth inhibitory activity of ethanol extracts of Chinese and Brazilian propolis in four human colon carcinoma cell lines," Oncology Reports, vol. 22, no. 2, pp. 349-354, 2009.
156. S. M. Messerli, M.-R. Ahn, K. Kunimasa et al., "Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice," Phytotherapy Research, vol. 23, no. 3, pp. 423-427, 2009.
157. S. Awale, F. Li, H. Onozuka, H. Esumi, Y. Tezuka, and S. Kadota, "Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition," Bioorganic and Medicinal Chemistry, vol. 16, no. 1, pp. 181-189, 2008.
158. H. Li, A. Kapur, J. X. Yang et al., "Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin," International Journal of Oncology, vol. 31, no. 3, pp. 601-606, 2007.
159. G. Ozturk, Z. Ginis, S. Akyol, G. Erden, A. Gurel, and O. Akyol, "The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers," European Review forMedical and Pharmacological Sciences, vol. 16, no. 15, pp. 2064-2068, 2012.
160. Y.-J. He, B.-H. Liu, D.-B. Xiang, Z.-Y. Qiao, T. Fu, and Y.-H. He, "Inhibitory effect of caffeic acid phenethyl ester on the growth of SW480 colorectal tumor cells involves β-catenin associated signaling pathway down-regulation," World Journal of Gastroenterology, vol. 12, no. 31, pp. 4981-4985, 2006.
161. C.-P. Chuu, H.-P. Lin, M. F. Ciaccio et al., "Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks," Cancer Prevention Research, vol. 5, no. 5, pp. 788-797, 2012.
162. J. Wu, C. Omene, J. Karkoszka et al., "Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer," Cancer Letters, vol. 308, no. 1, pp. 43-53, 2011.
163. C. Omene, M. Kalac, J. Wu, E. Marchi, K. Frenkel, and O. A. OConnor, "Propolis and its active component, caffeic acid phenethyl ester (CAPE), modulate breast cancer therapeutic targets via an epigenetically mediated mechanism of action," Journal of Cancer Science and Therapy, vol. 5, no. 10, pp. 334-342, 2013.
164. C. O. Omene, J. Wu, and K. Frenkel, "Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells," Investigational New Drugs, vol. 30, no. 4, pp. 1279-1288, 2012.
165. A. M. Alizadeh, H. Afrouzan, N. Dinparast-Djadid et al., "Chemoprotection of MNNG-initiated gastric cancer in rats using Iranian propolis," Archives of IranianMedicine, vol. 18, no. 1, pp. 18-23, 2015.
166. E. Szliszka, Z. P. Czuba, J. Bronikowska, A. Mertas, A. Paradysz, and W. Krol, "Ethanolic extract of propolis augments TRAILinduced apoptotic death in prostate cancer cells," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 535172, 11 pages, 2011.
167. E. Szliszka, G. Zydowicz, B. Janoszka, C. Dobosz, G. Kowalczyk-Ziomek, and W. Krol, "Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis," International Journal of Oncology, vol. 38, no. 4, pp. 941-953, 2011.
168. E. Szliszka and W. Krol, "Polyphenols isolated from propolis augment TRAIL-induced apoptosis in cancer cells," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 731940, 10 pages, 2013.
169. E. Szliszka, G. Zydowicz, E. Mizgala, and W. Krol, "Artepillin C (3, 5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis," International Journal of Oncology, vol. 41, no. 3, pp. 818-828, 2012.
170. K. McEleny, R. Coffey, C. Morrissey, J. M. Fitzpatrick, and R. W. G. Watson, "Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins," BJU International, vol. 94, no. 3, pp. 402-406, 2004.
171. V. Cavaliere, D. L. Papademetrio, T. Lombardo, S. N. Costantino, G. A. Blanco, and E. M. C. Alvarez, "Caffeic acid phenylethyl ester and MG132, two novel nonconventional chemotherapeutic agents, induce apoptosis of human leukemic cells by disrupting mitochondrial function," Targeted Oncology, vol. 9, no. 1, pp. 25-42, 2014.
172. K. W. Lee, N. J. Kang, J. H. Kim et al., "Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B," Genes and Nutrition, vol. 2, no. 4, pp. 319-322, 2008.
173. P. Saharinen, L. Eklund, K. Pulkki, P. Bono, and K. Alitalo, "VEGF and angiopoietin signaling in tumor angiogenesis and metastasis," Trends inMolecularMedicine, vol. 17, no. 7, pp. 347-362, 2011.
174. M.-R. Ahn, K. Kunimasa, T. Ohta et al., "Suppression of tumorinduced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation," Cancer Letters, vol. 252, no. 2, pp. 235-243, 2007.
175. T. Ohta, K. Kunimasa, M.-R. Ahn et al., "Brazilian propolis suppresses angiogenesis by inducing apoptosis in tubeforming endothelial cells through inactivation of survival signal ERK1/2," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 870753, 8 pages, 2011.
176. S. S. Yun, E. H. Park, J. J. Kyung, and C. Jin, "Inhibition of angiogenesis by propolis," Archives of Pharmacal Research, vol. 25, no. 4, pp. 500-504, 2002.
177. T. Ohta, K. Kunimasa, T. Kobayashi, M. Sakamoto, and K. Kaji, "Propolis suppresses tumor angiogenesis by inducing apoptosis in tube-forming endothelial cells," Bioscience, Biotechnology and Biochemistry, vol. 72, no. 9, pp. 2436-2440, 2008.
178. M. Keshavarz, A. Mostafaie, K. Mansouri, Y. Shakiba, and H. R. M. Motlagh, "Inhibition of corneal neovascularization with propolis extract," Archives ofMedical Research, vol. 40, no. 1, pp. 59-61, 2009.
179. H. Izuta, M. Shimazawa, K. Tsuruma, Y. Araki, S. Mishima, and H. Hara, "Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells," BMC Complementary and Alternative Medicine, vol. 9, article 45, 2009.
180. V. A. Isidorov, L. Szczepaniak, and S. Bakier, "Rapid GC/MS determination of botanical precursors of eurasian propolis," Food Chemistry, vol. 142, pp. 101-106, 2014.
181. S. D. Leonhardt, H. M. Wallace, and T. Schmitt, "The cuticular profiles of Australian stingless bees are shaped by resin of the eucalypt tree Corymbia torelliana," Austral Ecology, vol. 36, no. 5, pp. 537-543, 2011.
182. R. Christov, V. Bankova, I. Tsvetkova, A. Kujumgiev, and A. Delgado Tejera, "Antibacterial furofuran lignans from Canary Islands propolis," Fitoterapia, vol. 70, no. 1, pp. 89-92, 1999.
183. J. F. Campos, U. P. dos Santos, L. F. B. Macorini et al., "Antimicrobial, antioxidant and cytotoxic activities of propolis from Melipona orbignyi (Hymenoptera, Apidae)," Food and Chemical Toxicology, vol. 65, pp. 374-380, 2014.
184. A. Mavri, H. Abramovic, T. Polak et al., "Chemical properties and antioxidant and antimicrobial activities of Slovenian propolis," Chemistry and Biodiversity, vol. 9, no. 8, pp. 1545-1558, 2012.
185. A. A. Lopes, T. S. Ferreira, R. T. Nesi et al., "Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke," Bioorganic and Medicinal Chemistry, vol. 21, no. 24, pp. 7570-7577, 2013.
186. Y. Aliyazicioglu, S. Demir, I. Turan et al., "Preventive and protective effects of turkish propolis on H2O2-induced DNA damage in foreskin fibroblast cell lines," Acta Biologica Hungarica, vol. 62, no. 4, pp. 388-396, 2011.
187. M. E. Yonar, S. M. Yonar, M. S. Ural, S. Silici, and M. Dusukcan, "Protective role of propolis in chlorpyrifos-induced changes in the haematological parameters and the oxidative/antioxidative status of Cyprinus carpio carpio," Food and Chemical Toxicology, vol. 50, no. 8, pp. 2703-2708, 2012.
188. N. Orsolic, D. Sirovina, G. Gajski, V. Garaj-Vrhovac, M. Jazvinscak Jembrek, and I. Kosalec, "Assessment of DNA damage and lipid peroxidation in diabetic mice: effects of propolis and epigallocatechin gallate (EGCG)," Mutation Research, vol. 757, no. 1, pp. 36-44, 2013.
189. A. Rossi, R. Longo, A. Russo, F. Borrelli, and L. Sautebin, "The role of the phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung cyclooxygenase activity by propolis," Fitoterapia, vol. 73, supplement 1, pp. S30-S37, 2002.
190. O. Koksel, A. Ozdulger, L. Tamer et al., "Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats," Pulmonary Pharmacology and Therapeutics, vol. 19, no. 2, pp. 90-95, 2006.
191. M. M. M. Abdel-Latif, H. J. Windle, B. S. ElHomasany, K. Sabra, and D. Kelleher, "Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells," British Journal of Pharmacology, vol. 146, no. 8, pp. 1139-1147, 2005.
192. F. Missima, A. C. Pagliarone, C. L. Orsatti, J. P. Araujo Jr., and J. M. Sforcin, "The Effect of propolis on Th1/Th2 cytokine expression and production by melanoma-bearing mice submitted to stress," Phytotherapy Research, vol. 24, no. 10, pp. 1501-1507, 2010.
193. B. J. Conti, M. C. Bufalo, M. D. A. Golim, V. Bankova, and J. M. Sforcin, "Cinnamic acid is partially involved in propolis immunomodulatory action on human monocytes," Evidencebased Complementary and Alternative Medicine, vol. 2013, Article ID 109864, 7 pages, 2013.
194. G. Girgin, T. Baydar, M. Ledochowski et al., "Immunomodulatory effects of Turkish propolis: changes in neopterin release and tryptophan degradation," Immunobiology, vol. 214, no. 2, pp. 129-134, 2009.
195. J. H. Park, J. K. Lee, H. S. Kimet al., "Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice," International Immunopharmacology, vol. 4, no. 3, pp. 429-436, 2004.
196. S. Nolkemper, J. Reichling, K. H. Sensch, and P. Schnitzler, "Mechanism of herpes simplex virus type 2 suppression by propolis extracts," Phytomedicine, vol. 17, no. 2, pp. 132-138, 2010.
197. V. Bankova, A. Galabov, D. Antonova, N. Vilhelmova, and B. Di Perri, "Chemical composition of Propolis Extract ACF and activity against herpes simplex virus," Phytomedicine, vol. 21, no. 11, pp. 1432-1438, 2014.
198. K. Kuwata, T. Takemura, T. Urushisaki et al., "3, 4-dicaffeoylquinic acid, a major constituent of Brazilian propolis, increases TRAIL expression and extends the lifetimes of mice infected with the influenza a virus," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 946867, 7 pages, 2012.
199. M. P. Popova, I. B. Chinou, I. N. Marekov, and V. S. Bankova, "Terpenes with antimicrobial activity from Cretan propolis," Phytochemistry, vol. 70, no. 10, pp. 1262-1271, 2009.
200. H. F. Santana, A. A. T. Barbosa, S. O. Ferreira, and H. C. Mantovani, "Bactericidal activity of ethanolic extracts of propolis against Staphylococcus aureus isolated from mastitic cows," World Journal of Microbiology and Biotechnology, vol. 28, no. 2, pp. 485-491, 2012.
201. L. Netikova, P. Bogusch, and P. Heneberg, "Czech ethanolfree propolis extract displays inhibitory activity against a broad spectrum of bacterial and fungal pathogens," Journal of Food Science, vol. 78, no. 9, pp. M1421-M1429, 2013.
202. R. D. O. Orsi, J. M. Sforcin, S. R. Cunha Funari, A. Fernandes Jr., and V. Bankova, "Synergistic effect of propolis and antibiotics on the Salmonella typhi," Brazilian Journal of Microbiology, vol. 37, no. 2, pp. 108-112, 2006.
203. R. O. Orsi, J. M. Sforcin, S. R. C. Funari, and V. Bankova, "Effects of Brazilian and Bulgarian propolis on bactericidal activity of macrophages against Salmonella Typhimurium," International Immunopharmacology, vol. 5, no. 2, pp. 359-368, 2005.
204. Z. Yildirim, S. Hacievliyagil, N. O. Kutlu et al., "Effect of water extract of Turkish propolis on tuberculosis infection in guineapigs," Pharmacological Research, vol. 49, no. 3, pp. 287-292, 2004.
205. A. R. Khosravi, H. Shokri, D. Nikaein et al., "Yeasts as important agents of onychomycosis: in vitro activity of propolis against yeasts isolated from patients with nail infection," Journal of Alternative and Complementary Medicine, vol. 19, no. 1, pp. 57-62, 2013.
206. H. C. Kuo, W. H. Kuo, Y. J. Lee, W. L. Lin, F. P. Chou, and T. H. Tseng, "Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo," Cancer Letters, vol. 234, no. 2, pp. 199-208, 2006.
207. Y.-J. Chen, M.-S. Shiao, M.-L. Hsu, T.-H. Tsai, and S.-Y. Wang, "Effect of caffeic acid phenethyl ester, an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells," Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp. 5615-5619, 2001.
208. Y. Akao, H. Maruyama, K. Matsumoto et al., "Cell growth inhibitory effect of cinnamic acid derivatives from propolis on human tumor cell lines," Biological and Pharmaceutical Bulletin, vol. 26, no. 7, pp. 1057-1059, 2003.
209. H. Hattori, K. Okuda, T. Murase et al., "Isolation, identification, and biological evaluation of HIF-1-modulating compounds fromBrazilian green propolis," Bioorganic andMedicinal Chemistry, vol. 19, no. 18, pp. 5392-5401, 2011.
210. C. A. Dornelas, F. V. Fechine-Jamacaru, I. L. Albuquerque et al., "Angiogenesis inhibition by green propolis and the angiogenic effect of L-lysine on bladder cancer in rats," Acta Cirurgica Brasileira, vol. 27, no. 8, pp. 529-536, 2012.
211. J. B. Daleprane, T. Schmid, N. Dehne et al., "Suppression of hypoxia-inducible factor-1β contributes to the antiangiogenic activity of red propolis polyphenols in human endothelial cells," Journal of Nutrition, vol. 142, no. 3, pp. 441-447, 2012.
212. T. Kamiya, H. Nishihara, H. Hara, and T. Adachi, "Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress," Journal of Agricultural and Food Chemistry, vol. 60, no. 44, pp. 11065-11070, 2012.
213. H.-P. Lin, S. S. Jiang, and C.-P. Chuu, "Caffeic acid phenethyl ester causes p21CIP1 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells," PLoS ONE, vol. 7, no. 2, Article ID e31286, 2012.
214. Y.-Y. Kuo, H.-P. Lin, C. Huo et al., "Caffeic acid phenethyl ester suppresses proliferation and survival of TW2. 6 human oral cancer cells via inhibition of akt signaling," International Journal of Molecular Sciences, vol. 14, no. 5, pp. 8801-8817, 2013.
215. H. J. Hwang, H. J. Park, H.-J. Chung et al., "Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells," Journal of Nutritional Biochemistry, vol. 17, no. 5, pp. 356-362, 2006.
216. H. Seda Vatansever, K. Sorkun, S. Ismet Deliloglu Gurhan et al., "Propolis fromTurkey induces apoptosis through activating caspases in human breast carcinoma cell lines," Acta Histochemica, vol. 112, no. 6, pp. 546-556, 2010.
217. M. Watabe, K. Hishikawa, A. Takayanagi, N. Shimizu, and T. Nakaki, "Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells,"The Journal of Biological Chemistry, vol. 279, no. 7, pp. 6017-6026, 2004.
218. I. Valenca, F. Morais-Santos, V. Miranda-Goncalves, A. M. Ferreira, C. Almeida-Aguiar, and F. Baltazar, "Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro," BMC Complementary and Alternative Medicine, vol. 13, article 184, 2013.